Cargando…
Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site
BACKGROUND: The binding of HIV-1 Envelope glycoproteins (Env) to host receptor CD4 exposes vulnerable conserved epitopes within the co-receptor binding site (CoRBS) which are required for the engagement of either CCR5 or CXCR4 co-receptor to allow HIV-1 entry. Antibodies against this region have bee...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374964/ https://www.ncbi.nlm.nih.gov/pubmed/32693837 http://dx.doi.org/10.1186/s12915-020-00819-y |
_version_ | 1783561792219250688 |
---|---|
author | Tolbert, William D. Sherburn, Rebekah Gohain, Neelakshi Ding, Shilei Flinko, Robin Orlandi, Chiara Ray, Krishanu Finzi, Andrés Lewis, George K. Pazgier, Marzena |
author_facet | Tolbert, William D. Sherburn, Rebekah Gohain, Neelakshi Ding, Shilei Flinko, Robin Orlandi, Chiara Ray, Krishanu Finzi, Andrés Lewis, George K. Pazgier, Marzena |
author_sort | Tolbert, William D. |
collection | PubMed |
description | BACKGROUND: The binding of HIV-1 Envelope glycoproteins (Env) to host receptor CD4 exposes vulnerable conserved epitopes within the co-receptor binding site (CoRBS) which are required for the engagement of either CCR5 or CXCR4 co-receptor to allow HIV-1 entry. Antibodies against this region have been implicated in the protection against HIV acquisition in non-human primate (NHP) challenge studies and found to act synergistically with antibodies of other specificities to deliver effective Fc-mediated effector function against HIV-1-infected cells. Here, we describe the structure and function of N12-i2, an antibody isolated from an HIV-1-infected individual, and show how the unique structural features of this antibody allow for its effective Env recognition and Fc-mediated effector function. RESULTS: N12-i2 binds within the CoRBS utilizing two adjacent sulfo-tyrosines (TYS) for binding, one of which binds to a previously unknown TYS binding pocket formed by gp120 residues of high sequence conservation among HIV-1 strains. Structural alignment with gp120 in complex with the co-receptor CCR5 indicates that the new pocket corresponds to TYS at position 15 of CCR5. In addition, structure-function analysis of N12-i2 and other CoRBS-specific antibodies indicates a link between modes of antibody binding within the CoRBS and Fc-mediated effector activities. The efficiency of antibody-dependent cellular cytotoxicity (ADCC) correlated with both the level of antibody binding and the mode of antibody attachment to the epitope region, specifically with the way the Fc region was oriented relative to the target cell surface. Antibodies with poor Fc access mediated the poorest ADCC whereas those with their Fc region readily accessible for interaction with effector cells mediated the most potent ADCC. CONCLUSION: Our data identify a previously unknown binding site for TYS within the assembled CoRBS of the HIV-1 virus. In addition, our combined structural-modeling-functional analyses provide new insights into mechanisms of Fc-effector function of antibodies against HIV-1, in particular, how antibody binding to Env antigen affects the efficiency of ADCC response. |
format | Online Article Text |
id | pubmed-7374964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73749642020-07-22 Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site Tolbert, William D. Sherburn, Rebekah Gohain, Neelakshi Ding, Shilei Flinko, Robin Orlandi, Chiara Ray, Krishanu Finzi, Andrés Lewis, George K. Pazgier, Marzena BMC Biol Research Article BACKGROUND: The binding of HIV-1 Envelope glycoproteins (Env) to host receptor CD4 exposes vulnerable conserved epitopes within the co-receptor binding site (CoRBS) which are required for the engagement of either CCR5 or CXCR4 co-receptor to allow HIV-1 entry. Antibodies against this region have been implicated in the protection against HIV acquisition in non-human primate (NHP) challenge studies and found to act synergistically with antibodies of other specificities to deliver effective Fc-mediated effector function against HIV-1-infected cells. Here, we describe the structure and function of N12-i2, an antibody isolated from an HIV-1-infected individual, and show how the unique structural features of this antibody allow for its effective Env recognition and Fc-mediated effector function. RESULTS: N12-i2 binds within the CoRBS utilizing two adjacent sulfo-tyrosines (TYS) for binding, one of which binds to a previously unknown TYS binding pocket formed by gp120 residues of high sequence conservation among HIV-1 strains. Structural alignment with gp120 in complex with the co-receptor CCR5 indicates that the new pocket corresponds to TYS at position 15 of CCR5. In addition, structure-function analysis of N12-i2 and other CoRBS-specific antibodies indicates a link between modes of antibody binding within the CoRBS and Fc-mediated effector activities. The efficiency of antibody-dependent cellular cytotoxicity (ADCC) correlated with both the level of antibody binding and the mode of antibody attachment to the epitope region, specifically with the way the Fc region was oriented relative to the target cell surface. Antibodies with poor Fc access mediated the poorest ADCC whereas those with their Fc region readily accessible for interaction with effector cells mediated the most potent ADCC. CONCLUSION: Our data identify a previously unknown binding site for TYS within the assembled CoRBS of the HIV-1 virus. In addition, our combined structural-modeling-functional analyses provide new insights into mechanisms of Fc-effector function of antibodies against HIV-1, in particular, how antibody binding to Env antigen affects the efficiency of ADCC response. BioMed Central 2020-07-21 /pmc/articles/PMC7374964/ /pubmed/32693837 http://dx.doi.org/10.1186/s12915-020-00819-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Tolbert, William D. Sherburn, Rebekah Gohain, Neelakshi Ding, Shilei Flinko, Robin Orlandi, Chiara Ray, Krishanu Finzi, Andrés Lewis, George K. Pazgier, Marzena Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site |
title | Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site |
title_full | Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site |
title_fullStr | Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site |
title_full_unstemmed | Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site |
title_short | Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site |
title_sort | defining rules governing recognition and fc-mediated effector functions to the hiv-1 co-receptor binding site |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374964/ https://www.ncbi.nlm.nih.gov/pubmed/32693837 http://dx.doi.org/10.1186/s12915-020-00819-y |
work_keys_str_mv | AT tolbertwilliamd definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite AT sherburnrebekah definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite AT gohainneelakshi definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite AT dingshilei definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite AT flinkorobin definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite AT orlandichiara definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite AT raykrishanu definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite AT finziandres definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite AT lewisgeorgek definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite AT pazgiermarzena definingrulesgoverningrecognitionandfcmediatedeffectorfunctionstothehiv1coreceptorbindingsite |